Skip to main content

Find Clinical Trials

Home
Conditions
Untreated Resectable Pancreatic Adenocarcinoma

Clinical trial condition

Untreated Resectable Pancreatic Adenocarcinoma

Explore clinical trials studying Untreated Resectable Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Untreated Resectable Pancreatic Adenocarcinoma trial results

Completed

Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer

NCT04669197

Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Untreated Resectable Pancreatic Adenocarcinoma
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

View Trial Details